2. Metabolic Enzyme/Protease Neuronal Signaling GPCR/G Protein
  3. Endogenous Metabolite Dopamine Receptor
  4. Creatine

クレアチン  (Synonyms: Creatine)

製品番号: HY-W010388 純度: 99.51%
COA 取扱説明書 Technical Support

Creatine, an endogenous amino acid derivative, plays an important role in cellular energy, especially in muscle and brain.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 57-00-1

容量 価格（税別） 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in Water
ready for reconstitution
 USD 55 在庫あり
Solution
10 mM * 1 mL in Water USD 55 在庫あり
Solid
500 mg $50 在庫あり
5 g $60 在庫あり
10 g   お問い合わせ  
50 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 5 publication(s) in Google Scholar

Other Forms of Creatine:

クレアチン 関連抗体

Top Publications Citing Use of Products

    Creatine purchased from MedChemExpress. Usage Cited in: Proc Natl Acad Sci U S A. 2025 Sep 9;122(36):e2426135122.  [Abstract]

    SPR analysis showed Creatine (25 μM) binding to hCRT, with a dissociation constant (KD) of 3.2 μM.

    Creatine purchased from MedChemExpress. Usage Cited in: Cancer Immunol Res. 2025 Jun 4;13(6):939-956.  [Abstract]

    Creatine (10, 100, and 1,000 µmol/L; 24 h) stimulates type I IFN induction via the cGAMP–cGAS–STING–IRF3 signaling axis. 2030-cGAMP was robustly induced in monocytes following Creatine treatment.

    Creatine purchased from MedChemExpress. Usage Cited in: Cancer Immunol Res. 2025 Jun 4;13(6):939-956.  [Abstract]

    Examination of cGAS-STING downstream signaling in monocytes by flow cytometry revealed activation of the STING-TBK1-IRF3 signaling axis following Creatine (10, 100, and 1,000 µmol/L; 24 h) treatment.

    Creatine purchased from MedChemExpress. Usage Cited in: Cancer Immunol Res. 2025 Jun 4;13(6):939-956.  [Abstract]

    Combination of LNP-Gsdme and Creatine (10.5 mg/mice; once daily; IT) synergistically suppresses tumor growth. Tumor growth curves, tumor images, and tumor weights of B16F10 and 4T1 tumor–bearing mice treated with LNP-Gsdme/GFP or combined with Creatine.

    Creatine purchased from MedChemExpress. Usage Cited in: Cell Rep. 2025 Sep 1;44(9):116139.  [Abstract]

    The syngeneic mouse MC38 CRC model was utilized to examine how Creatine (oral gavage; 50 mg/mL; 400 μL/time; 3 times per week) supplementation, with or without the addition of anti-PD-1 antibody, affected tumor growth and survival. Tumor growth, tumor weights, and survival curves were recorded for the MC38 model mice given the different therapies. Combination therapy significantly suppressed tumor growth and prolonged survival of MC38 tumor-bearing immunocompetent C57BL/6 J mice compared to either single-agent or control-treated groups.

    Creatine purchased from MedChemExpress. Usage Cited in: Cell Rep. 2025 Sep 1;44(9):116139.  [Abstract]

    Tumor growth curve and tumor weights of DLD1 xenografts after indicated treatment.To ascertain whether Creatine (oral gavage; 50 mg/mL; 400 μL/time; 3 times per week) exhibits an inhibitory effect on tumor progression, a DLD-1 xenograft model was established, and Creatine was found to remarkably inhibit tumor development.

    Endogenous Metabolite アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    Human Endogenous Metabolite Microbial Metabolite

    Dopamine Receptor アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    Dopamine Receptor D1 Receptor D2 Receptor D3 Receptor D4 Receptor D5 Receptor

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Creatine, an endogenous amino acid derivative, plays an important role in cellular energy, especially in muscle and brain.

    IC50 & Target

    Microbial Metabolite

     

    Human Endogenous Metabolite

     

    Cellular Effect
    Cell Line Type Value Description References
    HEK293 EC50
    5 3
    Compound: 586
    Substrate uptake by the Sodium- and Chloride-Dependent Creatine Transporter 1 (CRTR, SLC6A8) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC6A8 cells (PubChem AID: 1794823)
    Substrate uptake by the Sodium- and Chloride-Dependent Creatine Transporter 1 (CRTR, SLC6A8) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC6A8 cells (PubChem AID: 1794823)
    		10.5281/zenodo.7360539
    HEK293 EC50
    5 3
    Compound: 586
    Substrate uptake by the Sodium- and Chloride-Dependent Creatine Transporter 1 (CRTR, SLC6A8) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC6A8 cells
    Substrate uptake by the Sodium- and Chloride-Dependent Creatine Transporter 1 (CRTR, SLC6A8) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC6A8 cells
    		10.5281/zenodo.7360539
    HEK293 EC50
    5 3
    Compound: 586
    Substrate uptake by the Sodium- and Chloride-Dependent Creatine Transporter 1 (CRTR, SLC6A8) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC6A8 cells (PubChem AID: 1794823)
    Substrate uptake by the Sodium- and Chloride-Dependent Creatine Transporter 1 (CRTR, SLC6A8) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC6A8 cells (PubChem AID: 1794823)
    		10.5281/zenodo.7360539
    体外実験

    Creatine (10-20 mM, 1-3 weeks) promotes the cell growth, differentiation and mineralization of osteoblast-like cells[2].
    Creatine (0.1-10 mM, 2-24 h) scanvages the free radicals, protects the DNA especially mtDNA from oxidative damage[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    クレアチン 関連抗体
    体内実験

    Creatine (0.1-1000 mg/kg, po, single dose) exhibits antidepressant-like activity in mouse tail suspension test, which could be enhanced by dopamine receptor agonist SKF38393 (HY-12520A) and Apomorphine (HY-12723)[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Mouse tail suspension test[4]
    Dosage: 0.1-1000 mg/kg
    Administration: po, single dose
    Result: Reduced the immobility time of mice in the tail suspension test.
    分子量

    131.13

    分子式

    C4H9N3O2
    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    CN(C(N)=N)CC(O)=O
    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.
    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    H2O : 6.25 mg/mL (47.66 mM; Need ultrasonic)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 7.6260 mL 38.1301 mL 76.2602 mL
    5 mM 1.5252 mL 7.6260 mL 15.2520 mL
    10 mM 0.7626 mL 3.8130 mL 7.6260 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始）

    C1

    ×
    体積 （開始）

    V1

    =
    濃度 （終了）

    C2

    ×
    体積 （終了）

    V2

    体内:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  PBS

      Solubility: 20 mg/mL (152.52 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
    純度とドキュメンテーション

    純度: 99.95%

    COA (243 KB) HNMR (221 KB) RP-HPLC (258 KB) MS (68 KB)

    取扱説明書 (2659 KB)
    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O 1 mM 7.6260 mL 38.1301 mL 76.2602 mL 190.6505 mL
    5 mM 1.5252 mL 7.6260 mL 15.2520 mL 38.1301 mL
    10 mM 0.7626 mL 3.8130 mL 7.6260 mL 19.0650 mL
    15 mM 0.5084 mL 2.5420 mL 5.0840 mL 12.7100 mL
    20 mM 0.3813 mL 1.9065 mL 3.8130 mL 9.5325 mL
    25 mM 0.3050 mL 1.5252 mL 3.0504 mL 7.6260 mL
    30 mM 0.2542 mL 1.2710 mL 2.5420 mL 6.3550 mL
    40 mM 0.1907 mL 0.9533 mL 1.9065 mL 4.7663 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Creatine Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Creatine57-00-1Endogenous MetaboliteDopamine ReceptorInhibitorinhibitorinhibit

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

    		  

    カスタマ需要量 *

    お名前 *

    		 

    タイトル

    メールアドレス *

    		 

    電話番号 *

    デパートメント

    		 

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

    		      

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Creatine
    製品番号:
    HY-W010388
    数量:
    MCE 日本正規代理店:

    カスタマーレビュー

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    製品名

    		  

    Lot #

    お名前 *

    		 

    メールアドレス *

    電話番号 *

    		 

    部門 *

    組纖名 *

    		 

    国或いは地域 *

    備考

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.